Nordic Life Science 1
TOP STORIES BUSINESS MIL E S T ONE a key mileston
e Evelina Vågesjö, CEO, and Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma D E V E L O PMEN T for Zelluna and marks an important aspect of our strategy, which is to expand our pipeline through in-licensing and partnering,” says Anders Holm, COO & Head of BD, Zelluna Immunotherapy. The collaboration will initially focus on the development of TCRNK products targeting Hepatitis B Virus (HBV), which is a leading cause of liver cancer and has a high unmet need for efficient treatment options. The company also recently announced the completion of a fundraise of approximately EUR 7.5 million to fully focus on the development of its TCR guided Natural Killer (NK) cell therapy platform (TCR-NK) for the treatment of cancers. The company is one of ten life science companies selected this year for Springboard Enterprises’ Health Innovation Hub: Life Science. 800 experienced entrepreneurs who make up the Springboard Alumnae Network. This year’s cohort will convene virtually over the next several months for the Health Innovation Hub Bootcamp, after which they will be matched with a personal advisory team, tasked with providing a meaningful impact on the company’s next stage of growth. Companies recruited and qualified by Springboard’s network of advisors are among the most promising companies led by some of the most talented and accomplished women entrepreneurs. 12 Ilya has also secured a total of 5.3 million EUR in funding from the European Innovation Council (EIC) Accelerator program of blended financing. The funds will enable Ilya Pharma to accelerate a Phase II Trial of its lead drug candidate ILP100, which has the potential to heal problematic non-healing wounds in diabetes, potentially up to 80% faster, and deliver savings to overburdened healthcare systems of 6 billion EUR annually. Ilya aims to open recruitment for Phase II in 2021 and is also currently closing an additional related 5 million EUR share issue. Anders Holm, COO, Zelluna Immunotherapy NORDICLIFESCIENCE.ORG PHOTO MIKAEL WALLERSTEDT PHOTO STIG JARNES